Ponoi Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,880,623
Closed -$63.6M 5
2021
Q2
$63.6M Hold
1,880,623
35.32% 1
2021
Q1
$44M Hold
1,880,623
25.87% 1
2020
Q4
$54.2M Buy
+1,880,623
New +$47.3M 30.99% 1

Ponoi Management's CNST Position: Q3 2021 in Review

Ponoi Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 1,880,623 shares — an estimated $63.6M sold.

Ponoi Management first reported a position in CNST in Q4 2020 and held it in 3 quarters. The position peaked at $63.6M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Ponoi Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Ponoi Management sold 1,880,623 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $63.6M.
  • Ponoi Management first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2020 and held it in 3 quarters.
  • Ponoi Management's Constellation Pharmaceuticals, Inc. position peaked at $63.6M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Ponoi Management's 13F filing for Q3 2021, filed 12 Nov 2021.